In this third installment of 3, Infection Control Today® continues the one father's story of how sepsis can enter central lines and how it affects the entire family.
In this 3-part video series, Infection Control Today® (ICT®) has presented a personal story of how sepsis can enter central lines. One father tells the story of how his son lived through sepsis but how, in the end, it has taken an enormous toll not only on his son but on his whole family.
The father in question, David Jordon, BS, key account manager for US hospitals for Covalon Technologies, talks to ICT® about his family’s story of how sepsis changed their lives. He describes his family’s pain, loneliness, and unbeatable strength to get through a trying time in their lives due to their son’s illness.
This story is also a tale of dedication, determination, and love.
In this third of 3 installments of David Jordan and his family’s story about his son living through sepsis and the aftermath, Jordan describes how it has affected his family’s life, his career, and what blessing they chose to do because of their son’s long-term illness. He discussed how his career has evolved into a position where he can work within health care to help prevent infections. Finally, Jordan covers how his personal story has changed how he approaches customers and patients about his product experience.
Jordan told ICT® in this exclusive interview that “When you're working with products that prevent infection, and you've been through that infection, you’re not talking about a clinical study. You're talking about a personal experience. And even if you don't get into your personal experience, there's a difference between talking about something that's preventing an infection when you've been through it versus ‘I heard about it.’”
The first installment is here.
The second installment is here.
Managing Multimorbidity and Polypharmacy in HIV: Insights From Michelle S. Cespedes, MD, MS
November 20th 2024Michelle S. Cespedes, MD, MS, discusses the challenges of managing multimorbidity and polypharmacy in HIV treatment, emphasizing patient education, evolving guidelines, and real-world insights from the REPRIEVE study.
Longhorn Vaccines and Diagnostics to Showcase Breakthrough Vaccine Data at IDWeek 2024
November 19th 2024Longhorn Vaccines and Diagnostics revealed promising data on universal influenza vaccine LHNVD-110 and AMR sepsis vaccine LHNVD-303 at IDWeek 2024, addressing critical global health challenges.
Infection Intel: Revolutionizing Ultrasound Probe Disinfection With Germitec's Chronos
November 19th 2024Learn how Germitec’s Chronos uses patented UV-C technology for high-level disinfection of ultrasound probes in 90 seconds, enhancing infection control, patient safety, and environmental sustainability.
CDC HICPAC Considers New Airborne Pathogen Guidelines Amid Growing Concerns
November 18th 2024The CDC HICPAC discussed updates to airborne pathogen guidelines, emphasizing the need for masks in health care. Despite risks, the committee resisted universal masking, highlighting other mitigation strategies
The Importance of Hand Hygiene in Clostridioides difficile Reduction
November 18th 2024Clostridioides difficile infections burden US healthcare. Electronic Hand Hygiene Monitoring (EHHMS) systems remind for soap and water. This study evaluates EHHMS effectiveness by comparing C difficile cases in 10 hospitals with CMS data, linking EHHMS use to reduced cases.